Literature DB >> 15223815

Ophthalmic drug delivery through contact lenses.

Derya Gulsen1, Anuj Chauhan.   

Abstract

PURPOSE: Currently available ophthalmic drug delivery systems are inefficient and may lead to side effects. To increase efficiency and reduce side effects, the authors propose disposable particle-laden soft contact lenses for ophthalmic drug delivery.
METHODS: The essential idea is to encapsulate the ophthalmic drug formulations in nanoparticles and to disperse these drug-laden particles in the lens material, such as poly-2-hydroxyethyl methacrylate (p-HEMA) hydrogels. The drug-laden p-HEMA hydrogels were synthesized by free radical solution polymerization of the monomers in presence of nanoparticles. The particle-laden hydrogels were characterized by light-transmission and electron microscopy studies. Release profiles of lidocaine, a model hydrophobic drug, were measured by UV-Vis spectrophotometry.
RESULTS: Microemulsions of hexadecane in water stabilized with a silica shell around the particles produced transparent hydrogels. Contact lenses made with particle-laden hydrogels released therapeutic levels of drug for a few days.
CONCLUSIONS: Particle-laden hydrogels are promising candidates for ophthalmic drug delivery. They are transparent and can release drugs for extended periods. The drug delivery rates can be controlled by varying the loading of nanoparticles in the gel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223815     DOI: 10.1167/iovs.03-0959

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  38 in total

1.  [Pharmacokinetics of the anterior eye].

Authors:  K Bell; N Pfeiffer; F H Grus
Journal:  Ophthalmologe       Date:  2014-02       Impact factor: 1.059

Review 2.  Wireless and battery-free platforms for collection of biosignals.

Authors:  Tucker Stuart; Le Cai; Alex Burton; Philipp Gutruf
Journal:  Biosens Bioelectron       Date:  2021-01-23       Impact factor: 10.618

Review 3.  Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.

Authors:  Jie Shen; Guang Wei Lu; Patrick Hughes
Journal:  Pharm Res       Date:  2018-09-25       Impact factor: 4.200

4.  Simulation of the hydrodynamic conditions of the eye to better reproduce the drug release from hydrogel contact lenses: experiments and modeling.

Authors:  A F R Pimenta; A Valente; J M C Pereira; J C F Pereira; H P Filipe; J L G Mata; R Colaço; B Saramago; A P Serro
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

5.  Release of Moxifloxacin From Corneal Collagen Shields.

Authors:  Siwei Zhou; Kristin M Hunt; Arman S Grewal; Kimberly M Brothers; Deepinder K Dhaliwal; Robert M Q Shanks
Journal:  Eye Contact Lens       Date:  2018-11       Impact factor: 2.018

Review 6.  Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.

Authors:  Michelle L Ratay; Elena Bellotti; Riccardo Gottardi; Steven R Little
Journal:  Adv Healthc Mater       Date:  2017-10-16       Impact factor: 9.933

7.  Extended release of ketotifen from silica shell nanoparticle-laden hydrogel contact lenses: in vitro and in vivo evaluation.

Authors:  Furqan A Maulvi; Mayurkumar A Mangukiya; Prachi A Patel; Rutvi J Vaidya; Akshay R Koli; Ketan M Ranch; Dinesh O Shah
Journal:  J Mater Sci Mater Med       Date:  2016-05-13       Impact factor: 3.896

8.  Topical Delivery of Senicapoc Nanoliposomal Formulation for Ocular Surface Treatments.

Authors:  Jie Liang Phua; Aihua Hou; Yuan Siang Lui; Tanima Bose; George Kanianthara Chandy; Louis Tong; Subbu Venkatraman; Yingying Huang
Journal:  Int J Mol Sci       Date:  2018-09-29       Impact factor: 5.923

9.  Dexamethasone diffusion across contact lenses is inhibited by Staphylococcus epidermidis biofilms in vitro.

Authors:  Kimberly M Brothers; Amy C Nau; Eric G Romanowski; Robert M Q Shanks
Journal:  Cornea       Date:  2014-10       Impact factor: 2.651

10.  A drug-eluting contact lens.

Authors:  Joseph B Ciolino; Todd R Hoare; Naomi G Iwata; Irmgard Behlau; Claes H Dohlman; Robert Langer; Daniel S Kohane
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-10       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.